{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:10:23Z","timestamp":1761894623896},"reference-count":72,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2007,10,1]],"date-time":"2007-10-01T00:00:00Z","timestamp":1191196800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"published-print":{"date-parts":[[2007,10]]},"DOI":"10.1157\/13109990","type":"journal-article","created":{"date-parts":[[2007,10,8]],"date-time":"2007-10-08T16:44:02Z","timestamp":1191861842000},"page":"535-548","source":"Crossref","is-referenced-by-count":3,"title":["Efectos de la infecci\u00f3n viral en el paciente trasplantado"],"prefix":"10.1016","volume":"25","author":[{"given":"Juan","family":"Jos\u00e9 Cast\u00f3n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9","family":"Miguel Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juli\u00e1n","family":"Torre-Cisneros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1157\/13109990_bib1","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1097\/01.tp.0000245676.43979.86","article-title":"A review of critical periods for opportunistic infection in the new transplantation era","volume":"15","author":"Garrido","year":"2006","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1399-0012.2006.00618.x","article-title":"Cytomegalovirus in transplantation: challenging the status quo","volume":"21","author":"Fishman","year":"2006","journal-title":"Clin Transplant"},{"key":"10.1157\/13109990_bib3","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1086\/514649","article-title":"Pneumonia after heart transplantation: A multi-institutional study","volume":"27","author":"Cisneros","year":"1998","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13109990_bib4","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1157\/13078802","article-title":"Documento de consenso de GESITRA-SEIMC sobre prevenci\u00f3n y tratamiento de la infecci\u00f3n por citomegalovirus en pacientes trasplantados","volume":"23","author":"Torre-Cisneros","year":"2005","journal-title":"Enferm Infecc Microbiol Clin"},{"key":"10.1157\/13109990_bib5","unstructured":"P\u00e9rez-Sola M, Cast\u00f3n JJ, Solana R, Rivero A, Torre-Cisneros J. Indirect effects of cytomegalovirus infection in solid organ transplant recipients. Enferm Infecc Microbiol Clin (en prensa)."},{"key":"10.1157\/13109990_bib6","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1378\/chest.06-0767","article-title":"Risk factors for pulmonary Aspergillus terreus infection in patients with positive culture for filamentous fungi","volume":"131","author":"Cast\u00f3n","year":"2007","journal-title":"Chest"},{"key":"10.1157\/13109990_bib7","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1056\/NEJM199905133401903","article-title":"Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation","volume":"340","author":"Lowance","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1157\/13109990_bib8","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1111\/j.1600-6143.2004.00451.x","article-title":"Cytomegalovirus prophylaxis and graft outcome in solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1157\/13109990_bib9","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1002\/lt.20523","article-title":"Impact of cytomegalovirus prophylaxis on rejection following orthotopic liver transplantation","volume":"11","author":"Slifkin","year":"2005","journal-title":"Liver Transpl"},{"key":"10.1157\/13109990_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1161\/01.CIR.100.1.61","article-title":"Impact of prophylactic immediate posttransplant ganciclovir on development of transplant atherosclerosis: a post hoc analysis of a randomized, placebo-controlled study","volume":"100","author":"Valantine","year":"1999","journal-title":"Circulation"},{"key":"10.1157\/13109990_bib11","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1016\/S0140-6736(05)66553-1","article-title":"Antiviral medications to prevent cytomegalovirus disease and early death in recipients of solid-organ transplants: a systematic review of randomised controlled trials","volume":"365","author":"Hodson","year":"2005","journal-title":"Lancet"},{"key":"10.1157\/13109990_bib12","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1046\/j.1469-0691.2002.00510.x","article-title":"Preemptive oral ganciclovir can reduce the risk of cytomegalovirus disease in liver transplant recipients","volume":"8","author":"Torre-Cisneros","year":"2002","journal-title":"Clin Microbiol Infect"},{"key":"10.1157\/13109990_bib13","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1097\/01.TP.0000157867.98649.F5","article-title":"Indirect outcomes associated with cytomegalovirus (opportunistic infections, hepatitis C virus sequelae, and mortality) in liver-transplant recipients with the use of preemptive therapy for 13 years","volume":"79","author":"Singh","year":"2005","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib14","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1093\/ndt\/gfg302","article-title":"Pre-emptive therapy of CMVpp65 antigen positive renal transplant recipients with oral ganciclovir: a randomized, comparative study","volume":"18","author":"Sagedal","year":"2003","journal-title":"Nephrol Dial Transplant"},{"key":"10.1157\/13109990_bib15","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1016\/S0041-1345(00)02685-3","article-title":"Antiviral drugs can inhibit lymphocyte apoptosis induced by cytomegalovirus antigens","volume":"33","author":"Briceno","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1157\/13109990_bib16","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1097\/01.tp.0000226071.12562.1a","article-title":"Impact of cytomegalovirus in organ transplant recipients in the era of antiviral prophylaxis","volume":"81","author":"Limaye","year":"2006","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib17","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S0140-6736(00)02607-6","article-title":"Emergence of ganciclovir-resistant cytomegalovirus disease among solid organ transplant recipients","volume":"356","author":"Limaye","year":"2000","journal-title":"Lancet"},{"key":"10.1157\/13109990_bib18","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1600-6143.2004.00382.x","article-title":"Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients","volume":"4","author":"Paya","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1157\/13109990_bib19","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1182\/blood.V83.7.1971.1971","article-title":"Recovery of HLA restricted cytomegalovirus-specific T-cell responses after allogeneic bone marrow transplant: correlation with CMV disease and effect of ganciclovir prophylaxis","volume":"83","author":"Li","year":"1994","journal-title":"Blood"},{"key":"10.1157\/13109990_bib20","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1007\/s10096-002-0863-5","article-title":"Delayed occurrence of cytomegalovirus disease in organ transplant recipients receiving antiviral prophylaxis are we winning the battle only to lose the war?","volume":"21","author":"Singh","year":"2002","journal-title":"Eur J Clin Microbiol Infect"},{"key":"10.1157\/13109990_bib21","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1182\/blood.V99.6.1978","article-title":"Incidence and outcome of cytomegalovirus infections following nonmyeloablative compared with myeloablative allogeneic stem cell transplantation, a matched control study","volume":"99","author":"Junghanss","year":"2002","journal-title":"Blood"},{"key":"10.1157\/13109990_bib22","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/j.jinf.2004.10.014","article-title":"Quantitative pp65 antigenemia in the diagnosis of cytomegalovirus disease: prospective assessment in a cohort of solid organ transplant recipients","volume":"58","author":"Bernabeu-Wittel","year":"2005","journal-title":"J Infect"},{"key":"10.1157\/13109990_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/j.1432-2277.2006.00416.x","article-title":"Presentation and early detection of post-transplant lymphoproliferative disorder after solid organ transplantation","volume":"20","author":"Bakker","year":"2007","journal-title":"Transplant International"},{"key":"10.1157\/13109990_bib24","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1097\/01.TP.0000144335.39913.5C","article-title":"Differences between early and late posttransplant lymphoproliferative disorders in solid organ transplant patients: are they two different diseases?","volume":"79","author":"Ghobrial","year":"2005","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib25","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1046\/j.1600-6143.2003.00325.x","article-title":"Lymphomas after solid organ transplantation: a collaborative transplant study report","volume":"4","author":"Opelz","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1157\/13109990_bib26","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1097\/01.TP.0000063934.89714.19","article-title":"Immunosuppressive TOR kinase inhibitor everolimus (RAD) suppresses growth of cells derived from posttransplant lymphoproliferative disorder at allograft-protecting doses","volume":"75","author":"Majewski","year":"2003","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib27","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/01.TP.0000055098.96022.F7","article-title":"Epstein-Barr virus seronegativity is a risk factor for late-onset posttransplant lymphoroliferative disorder in adult renal allograft recipients","volume":"75","author":"Shahinian","year":"2003","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib28","doi-asserted-by":"crossref","first-page":"3150","DOI":"10.1182\/blood-2002-10-3092","article-title":"Therapeutic LMP1 polyepitope vaccine for EBV-associated Hodgkin disease and nasopharyngeal carcinoma","volume":"101","author":"Duraiswamy","year":"2003","journal-title":"Blood"},{"key":"10.1157\/13109990_bib29","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1086\/514142","article-title":"Posttransplant lymphoproliferative disease in primary Epstein-Barr virus infection after liver transplantation: the role of cytomegalovirus disease","volume":"176","author":"Ma\u00f1ez","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1157\/13109990_bib30","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1111\/j.1399-0012.2005.00342.x","article-title":"Early onset post-transplant lymphoproliferative disease is associated with allograft localization","volume":"19","author":"Bakker","year":"2005","journal-title":"Clin Transplant"},{"key":"10.1157\/13109990_bib31","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1080\/10428190290016971","article-title":"Role of Epstein-Barr virus DNA load monitoring in prevention and early detection of post-transplant lymphoproliferative disease","volume":"43","author":"Stevens","year":"2002","journal-title":"Leuk Lymphoma"},{"key":"10.1157\/13109990_bib32","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1365-2141.2003.04540.x","article-title":"Epstein-Barr virus (EBV) load and interleukin-10 in EBV-positive and EBV-negative post-transplant lymphoproliferative disorders","volume":"122","author":"Muti","year":"2003","journal-title":"Br J Haematol"},{"key":"10.1157\/13109990_bib33","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1111\/j.1432-2277.2006.00284.x","article-title":"Management of patients with post-transplant lymproproliferative disorder: the role of rituximab","volume":"19","author":"Svoboda","year":"2006","journal-title":"Transplant International"},{"key":"10.1157\/13109990_bib34","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1097\/00007890-200104270-00012","article-title":"Reduction in immunosuppression as initial therapy for posttransplant lymphoproliferative disorder: analysis of prognostic variables and longterm follow-up of 42 adult patients","volume":"71","author":"Tsai","year":"2001","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib35","doi-asserted-by":"crossref","first-page":"3053","DOI":"10.1182\/blood-2005-01-0377","article-title":"Efficacy and safety of rituximab in B-cell post-transplantation lymphoproliferative disorders: results of a prospective multicenter phase 2 study","volume":"107","author":"Choquet","year":"2006","journal-title":"Blood"},{"key":"10.1157\/13109990_bib36","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1182\/blood.V106.11.936.936","article-title":"Treatmente of post-transplant lymphoproliferative disorder (PTLD) with rituximab or chemotherapy: the University of Pennsylvania experience","volume":"106","author":"Elstrom","year":"2005","journal-title":"Blood"},{"issue":"Suppl 1","key":"10.1157\/13109990_bib37","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/S1386-6532(06)70018-X","article-title":"Human herpesvirus-6 infection in solid organ and stem cell transplant recipients","volume":"37","author":"Ljungman","year":"2006","journal-title":"J Clin Virol"},{"issue":"Suppl 10","key":"10.1157\/13109990_bib38","first-page":"89","article-title":"Guidelines for the prevention and management of infectious complications of solid organ transplantation","volume":"10","author":"Green","year":"2004","journal-title":"Am J Transplant"},{"key":"10.1157\/13109990_bib39","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1097\/01.tp.0000229938.12722.ee","article-title":"A prospective survey of human herpesvirus-6 primary infection in solid organ transplant recipients","volume":"82","author":"Cervera","year":"2006","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib40","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1034\/j.1399-0012.2003.02104.x","article-title":"Detection of simultaneous beta-herpesvirus infections in clinical syndromes due to defined cytomegalovirus infection","volume":"17","author":"Razonable","year":"2003","journal-title":"Clin Transplant"},{"key":"10.1157\/13109990_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/01.tp.0000195771.83614.0b","article-title":"Pretransplant human herpesvirus 6 infection of patients with acute liver failure is a risk factor for posttransplant human herpesvirus 6 infection of the liver","volume":"81","author":"Harma","year":"2006","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib42","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1034\/j.1600-6143.2002.20511.x","article-title":"Interactions between cytomegalovirus, human herpesvirus-6, and the recurrence of hepatitis C after liver transplantation","volume":"2","author":"Humar","year":"2002","journal-title":"Am J Transplant"},{"key":"10.1157\/13109990_bib43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1038\/sj.bmt.1703423","article-title":"Ganciclovir is effective for prophylaxis and treatment of human herpesvirus-6 in allogeneic stem cell transplantation","volume":"29","author":"Tokimasa","year":"2002","journal-title":"Bone Marrow Transplant"},{"key":"10.1157\/13109990_bib44","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1056\/NEJM200004063421407","article-title":"Kaposi's sarcoma","volume":"342","author":"Antman","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1157\/13109990_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/00007890-200007270-00030","article-title":"Persistent human herpesvirus 8 viremia before Kaposi's sarcoma development in a liver transplant recipient","volume":"70","author":"Pozo","year":"2000","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib46","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1200\/JCO.1997.15.6.2371","article-title":"Treatment of Kaposi's sarcoma after solid organ transplantation","volume":"15","author":"Cole","year":"1997","journal-title":"J Clin Oncol"},{"key":"10.1157\/13109990_bib47","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1097\/00007890-199905150-00007","article-title":"Human herpes virus-8 and other risk factors for Kaposi's sarcoma in kidney transplant recipients. Groupe Cooperatif de Transplantation d\u2019\u00cele de France (GCIF)","volume":"67","author":"Tuppin","year":"1999","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib48","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1097\/00007890-199904270-00022","article-title":"Relationship of HHV8 replication and Kaposi's sarcoma after solid organ transplantation","volume":"67","author":"M\u00e9ndez","year":"1999","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib49","series-title":"Transplants infections","first-page":"350","article-title":"Herpes simplex and varicella zoster virus infection after hematopoietic stem cell or solid organ transplantation","author":"Gnann","year":"2003"},{"key":"10.1157\/13109990_bib50","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1097\/00007890-199004000-00016","article-title":"Herpes simplex virus infection in heart-lung transplant recipients","volume":"49","author":"Smyth","year":"1990","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib51","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1093\/infdis\/158.1.124","article-title":"Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies","volume":"158","author":"Singh","year":"1988","journal-title":"J Infect Dis"},{"key":"10.1157\/13109990_bib52","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1016\/S0041-1345(03)00652-3","article-title":"Characteristics and repercussion of varicella-zoster virus infection in cardiac transplant","volume":"35","author":"Cabez\u00f3n Ruiz","year":"2003","journal-title":"Transplant Proc"},{"key":"10.1157\/13109990_bib53","first-page":"145","article-title":"Acyclovir and renal transplantation","volume":"47","author":"Petterson","year":"1985","journal-title":"Scand J Infect Dis"},{"issue":"RR-6","key":"10.1157\/13109990_bib54","first-page":"1","article-title":"Update recommendations of the Advisory Committee on Immunization Practices (ACIP)","volume":"48","year":"1999","journal-title":"MMWR Recomm Rep"},{"key":"10.1157\/13109990_bib55","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1034\/j.1399-0012.2002.1o034.x","article-title":"Impact of hepatitis B and C on graft loss and mortality of patients after kidney transplantation","volume":"16","author":"Breitenfeldt","year":"2002","journal-title":"Clin Transplant"},{"key":"10.1157\/13109990_bib56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1034\/j.1399-0012.2000.140305.x","article-title":"Levels of HBV-DNA end Hbs-Ag after acute allograft rejection treatment by corticoids and OKT3","volume":"14","author":"Gonz\u00e1lez","year":"2000","journal-title":"Clin Transplant"},{"key":"10.1157\/13109990_bib57","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1034\/j.1600-6143.2001.10214.x","article-title":"Approach to the management of allograft recipients following the detection of hepatitis B virus in the prospective organ donor","volume":"1","author":"Chung","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1157\/13109990_bib58","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1097\/00007890-199501270-00014","article-title":"The risk of transmission of hepatitis B from HBsAg(\u2212), HBcAb(+), HBIgM(\u2212) organ donors","volume":"59","author":"Wachs","year":"1995","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib59","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/S0140-6736(99)07239-6","article-title":"Are booster immunizations needed for lifelong hepatitis B immunity?","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1157\/13109990_bib60","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1034\/j.1600-6143.2001.10213.x","article-title":"Hepatitis C virus seropositivity at the time of renal transplantation in the United States: associated factors and patient survival","volume":"1","author":"Batty","year":"2001","journal-title":"Am J Transplant"},{"key":"10.1157\/13109990_bib61","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1097\/00007890-200007270-00001","article-title":"Renal disease associated with hepatitis C infection after kidney and liver transplantation","volume":"70","author":"Baid","year":"2000","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib62","doi-asserted-by":"crossref","first-page":"1374","DOI":"10.1046\/j.1523-1755.1998.00883.x","article-title":"Effects of hepatitis C infection and renal transplantation on survival in end-stage renal disease","volume":"53","author":"Pereira","year":"1998","journal-title":"Kidney Int"},{"key":"10.1157\/13109990_bib63","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0891-5520(05)70130-6","article-title":"Viral hepatitis in the liver transplant recipient","volume":"14","author":"Rosen","year":"2000","journal-title":"Infect Dis Clin North Am"},{"key":"10.1157\/13109990_bib64","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1681\/ASN.2004121113","article-title":"Viral infection in the renal transplant recipient","volume":"16","author":"Kotton","year":"2005","journal-title":"J Am Soc Nephrol"},{"key":"10.1157\/13109990_bib65","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1681\/ASN.V1051080","article-title":"Polyomavirus infection of renal allograft recipients: from latent infection to manifest disease","volume":"10","author":"Nickeleit","year":"1999","journal-title":"J Am Soc Nephrol"},{"key":"10.1157\/13109990_bib66","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1056\/NEJMoa020439","article-title":"Prospective study of polyomavirus type BK replication and nephropathy in renal-transplant recipients","volume":"347","author":"Hirsch","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1157\/13109990_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00007890-200301150-00020","article-title":"Quantitative viral load monitoring and cidofovir therapy for the management of BK virus-associated nephropathy in children and adults","volume":"75","author":"Vats","year":"2003","journal-title":"Transplantation"},{"key":"10.1157\/13109990_bib68","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1086\/504812","article-title":"Parvovirus B19 infection after transplantation: a review of 98 cases","volume":"43","author":"Eid","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1157\/13109990_bib69","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1056\/NEJM198908243210807","article-title":"Pure red-cell aplasia of 10 years\u2019duration due to persistent Parvovirus B19 infection and its cure with immunoglobulin therapy","volume":"321","author":"Kurtzman","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1157\/13109990_bib70","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1038\/sj.bmt.1703139","article-title":"Respiratory virus infections after stem cell transplantation: a prospective study from the Infectious Diseases Working Party of the European Group for Blood and Marrow Transplantation","volume":"28","author":"Ljungman","year":"2001","journal-title":"Bone Marrow Transplant"},{"key":"10.1157\/13109990_bib71","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.qco.0000172697.44784.ff","article-title":"Emerging viral infections in transplant recipients","volume":"18","author":"Kumar","year":"2005","journal-title":"Current Opin Infect Dis"},{"key":"10.1157\/13109990_bib72","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1056\/NEJM199806113382407","article-title":"Infection in organ transplant recipients","volume":"338","author":"Fishman","year":"1998","journal-title":"N Engl J Med"}],"container-title":["Enfermedades Infecciosas y Microbiolog\u00eda Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743471?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0213005X07743471?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,8,25]],"date-time":"2021-08-25T09:40:37Z","timestamp":1629884437000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0213005X07743471"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,10]]},"references-count":72,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2007,10]]}},"alternative-id":["S0213005X07743471"],"URL":"https:\/\/doi.org\/10.1157\/13109990","relation":{},"ISSN":["0213-005X"],"issn-type":[{"value":"0213-005X","type":"print"}],"subject":[],"published":{"date-parts":[[2007,10]]}}}